Ministers unveil £6bn science strategy

Critics say more funds needed for research and development

Barclays says universal banking is ‘dead’

Chief executive says investment needed is big challenge

New ways of attacking cancer cells are being developed

Juno IPO highlights latest buzz in US biotech

Cell therapy specialist poised for listing as sector draws investors

Investors bank on Lending Club success

IPO price surge suggests the market sees an Alibaba in the making

Small-cap Week, December 13

IGas Energy, Motive Television, Iomart and Zytronic

Stephen Hawking

Stephen Hawking: Superhero of science

The life and works of the astrophysicist enthral the public in his books and on the big screen

Momo app screengrab

Chinese dating app shares surge on debut

Shares in Tinder-like service Momo surge 26% on Nasdaq debut

Risks high for Microsoft amid cloud gains

Technology group begins to cut the Windows cord

Apple supplier Wintek closes China plants

Touchscreen maker axes 7,000 jobs and leaves creditors chasing debts

Drug resistance to cost $100tn by 2050

UK review urges global action to tackle threat

Surgeons turn to 3D and nanorobots to enhance human judgment and skill

Modern developments are helping transform operating procedures and their results

Emphasis shifts from illness care to well care

Technology in development will help keep watch on how people are feeling between their visits to the doctor

Theory on origin of oceans dented

Data from Rosetta spacecraft fail to support prevailing thesis

IT incumbents learn to love the cloud

Established groups are keen to demonstrate they are still relevant

Tycoon to return Nobel medal to Watson

Russian billionaire praises work of DNA biologist ostracised for linking intelligence to race

Six solutions to a water shortage

The role of new technologies in easing chronic problems

Why the Valley struggles to conquer Europe

US technology groups must learn Brussels’ language, writes Karl-Theodor zu Guttenberg

Superbug threat drives $9.5bn Merck deal

Cubist purchase shows fresh interest in antibiotics to fight life-threatening infections

Driverless cars wait for green light

Legal and technological hurdles have to be overcome

Old drugs put under the microscope

Big pharma offers 68-strong library of compounds for fresh research

COMPANIES NEWS ON TWITTER

More FT Twitter accounts
SHARE THIS QUOTE